Hybridoma technology is a pivotal method in biotechnology for producing monoclonal antibodies (mAbs), which are crucial in diagnostics, therapeutics, and research. This technology involves fusing B-lymphocytes with myeloma cells to create hybridoma cells that can produce large quantities of specific antibodies. The success of hybridoma cell culture depends significantly on the quality and composition of the cell culture medium used.
Key Benefits of Hybridoma Cell Culture Media:
- Flexible and Versatile Formulation: Our media are free from animal-derived components, serum, and proteins, making them ideal for biopharmaceutical applications. They are ready-to-use and can be easily scaled up for large-volume cultures.
- Supports Various Cell Types: Suitable for both suspension and stationary hybridoma and myeloma cells, offering flexibility in cell culture methods.
- Customizable Solutions: We offer customization options through supplementation and packaging to meet specific customer needs.
The Power of Hybridoma Technology:
- Hybridoma technology has revolutionized the biotech industry by enabling the production of monoclonal antibodies (mAbs). This technology involves fusing B-lymphocytes with tumor cells to create immortal hybridoma cells that produce specific antibodies.
- Despite advancements in other platforms, hybridoma technology remains widely used after over 45 years, including in large-scale perfusion cultures. Our products cater to the needs of both diagnostic and biopharmaceutical customers.
HybridomaPlus: The Ultimate Solution for Antibody Production
- Simplified Antibody Production: HybridomaPlus offers a straightforward and safe method for producing a variety of antibodies using both recombinant myeloma lines and traditional hybridoma cells. This ready-to-use medium is free from animal-derived components, serum, and proteins.
- Optimized for Biotech Manufacturing: Designed to support rapid initial cell growth and high levels of antibody expression, HybridomaPlus ensures a clean environment for cell culture by avoiding factors that complicate downstream processing and final product purification.
